Ionis Pharmaceuticals, Inc. · 12 hours ago
2026 Summer Intern | Neuroscientist (Toxicology Research Group)
Carlsbad, CA
Internship
Hybrid
Intern
$18/hr - $23/hr
Start in 2026 SummerIonis Pharmaceuticals, Inc. is a pioneer in RNA-targeted medicines, dedicated to transforming lives for patients with serious diseases. The Toxicology Research Group is seeking a 2026 summer intern to investigate siRNA associated neurotoxicity in the CNS, providing hands-on experience in a biotech lab and enhancing research skills.
BiotechnologyHealth CareMedicalPharmaceutical
No H1B
Responsibilities
Work on a project investigating small interfering RNA (siRNA) associated neurotoxicity in the CNS
Gain experience in mouse ICV (Intracerebroventricular) surgery, rodent handling and observation, tissue collection, and RNA extraction for qPCR and DGE (Differential Gene Expression)
Learn how to design an experiment, interpret results and present findings
Qualification
Required
MUST have a High School Diploma or GED
MUST be currently enrolled in a U.S. Undergraduate Degree Program and not graduating prior to the completion of the Ionis internship
MUST be able to begin internship between 6/8/26 and no later than 6/14/26
MUST be able and willing to commit to a minimum 40-hour work week
MUST be able and willing to remain in program through at least 8/14/26
MUST have local housing and means of transportation
Benefits
Weekly stipend (for onsite interns only)
Housing/Travel assistance available for eligible, out-of-area interns
Networking and bonding social events
Company
Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases.
Founded in 1989
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.45B2025-11-13Post Ipo Debt· $700M
2024-09-09Post Ipo Equity· $500.3M
2023-06-06Post Ipo Debt· $500M
Leadership Team
Brett P. Monia
Chief Executive Officer
Eric Bastings
Senior Vice President, Development Strategy
Recent News
Labiotech UG
2026-01-22
Business Wire
2026-01-22
Company data provided by crunchbase